Metrics to compare | NNNN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNNNNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 73.0x | 19.9x | −0.4x | |
PEG Ratio | 0.45 | 0.36 | 0.00 | |
Price/Book | 15.5x | 3.0x | 2.6x | |
Price / LTM Sales | 54.1x | 2.7x | 3.0x | |
Upside (Analyst Target) | - | 63.2% | 54.3% | |
Fair Value Upside | Unlock | 4.7% | 8.4% | Unlock |
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.